Who are the Institutional Holders in Harvard Bioscience Inc (HBIO)?

Harvard Bioscience Inc (NASDAQ: HBIO) is -86.33% lower on its value in year-to-date trading and has touched a low of $0.28 and a high of $3.60 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HBIO stock was last observed hovering at around $0.41 in the last trading session, with the day’s gains setting it 0.04%.

Currently trading at $0.45, the stock is -2.37% and 5.23% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.9 million and changing 12.07% at the moment leaves the stock -65.15% off its SMA200. HBIO registered -78.49% loss for a year compared to 6-month loss of -77.53%. The firm has a 50-day simple moving average (SMA 50) of $0.4262 and a 200-day simple moving average (SMA200) of $1.3361.

The stock witnessed a -10.86% gain in the last 1 month and extending the period to 3 months gives it a 14.91%, and is -1.22% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.16% over the week and 9.65% over the month.

Harvard Bioscience Inc (HBIO) has around 355 employees, a market worth around $20.07M and $91.40M in sales. Fwd P/E is 7.57. Profit margin for the company is -63.52%. Distance from 52-week low is 61.36% and -87.39% from its 52-week high. The company has generated returns on investments over the last 12 months (-263.09%).

The EPS is expected to grow by 16.67% this year

123.0 institutions hold shares in Harvard Bioscience Inc (HBIO), with institutional investors hold 75.94% of the company’s shares. The shares outstanding are 44.21M, and float is at 37.41M with Short Float at 4.35%. Institutions hold 69.66% of the Float.

The top institutional shareholder in the company is BLACKROCK INC. with over 2.84 million shares valued at $8.1 million. The investor’s holdings represent 6.5392 of the HBIO Shares outstanding. As of 2024-06-30, the second largest holder is PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. with 2.77 million shares valued at $7.9 million to account for 6.3752 of the shares outstanding. The other top investors are HARVEY PARTNERS, LLC which holds 2.56 million shares representing 5.8812 and valued at over $7.29 million, while AMH EQUITY LTD holds 5.0589 of the shares totaling 2.2 million with a market value of $6.27 million.

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.